Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rambaldi

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
Bone Marrow Transplantation|September 27, 2016
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remissionF Saraceni, B Bruno, R M Lemoli, et al.
Leukemia|September 6, 2013
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMTA Ruggeri, G Sanz, H Bittencourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.
Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groupsR Bassan, E Pogliani, P Casula, et al.
Leukemia|February 16, 2000
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphomaL Fassone, K Bhatia, M Gutierrez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 3, 2017
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paperL Sarmati, M Andreoni, G Antonelli, et al.
Blood Cancer Journal|July 12, 2014
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemiaR Bassan, O Spinelli, E Oldani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Blood Cancer Journal|December 1, 2015
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaT Barbui, A M Vannucchi, V Buxhofer-Ausch, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
Bone Marrow Transplantation|September 27, 2016
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remissionF Saraceni, B Bruno, R M Lemoli, et al.
Leukemia|September 6, 2013
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMTA Ruggeri, G Sanz, H Bittencourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.
Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groupsR Bassan, E Pogliani, P Casula, et al.
Leukemia|February 16, 2000
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphomaL Fassone, K Bhatia, M Gutierrez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 3, 2017
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paperL Sarmati, M Andreoni, G Antonelli, et al.
Blood Cancer Journal|July 12, 2014
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemiaR Bassan, O Spinelli, E Oldani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Blood Cancer Journal|December 1, 2015
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaT Barbui, A M Vannucchi, V Buxhofer-Ausch, et al.
Pageof 24